App-Quantinova.ai

Pregnancy associated stroke and hypertension: a national cohort evaluating temporal trends, risk factors, and mortality

Ghamar Bitar - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Temporal trends in pregnancy associated stroke: risk factors and associated outcomes, a national cohort

Ghamar Bitar - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Predicting severe maternal morbidity at admission for delivery using intelligible machine learning

Zifei Xu - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Rates of venous thromboembolism in pregnant patients with active malignancy: a systematic review

Christopher M. Nash - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

High rates of venous thromboembolism among deliveries complicated by cancer

Jennifer J. Cate - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Outcomes in women with body mass index 60 kg/m2: planned cesarean versus attempted vaginal delivery

Jerri A. Waller - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Preterm preeclampsia and thromboembolism risk in pregnant and postpartum patients

Lara Slesnick - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Maternal morbidity and pregnancy latency in expectant management of severe pre-eclampsia

Carmen M. Avram - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Comparison of piperacillin/tazobactam versus standard antibiotic regimens for the treatment of intrapartum clinical chorioamnionitis

Celeste Swain - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Piperacillin/tazobactam

Comparison of four risk assessment tools for postpartum pharmacologic thromboprophylaxis

Sonia Sajja - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Contemporary Nationwide Estimates For Outcomes Associated With Craniotomy Among Patients With Intracerebral Hemorrhage

Abdulaziz T Bako - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Cerebral Venous Sinus Thrombosis After Covid-19 Vaccination In Korea: A Nationwide Cohort Study

Sang Joon An - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Factors Associated With Delayed Diagnosis Of Cerebral Venous Thrombosis: Secondary Analysis Of ACTION-CVT Study

Ekaterina Bakradze - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Hypoperfusion And Thromboembolism Are Codominant Stroke Mechanisms In Adult Moyamoya Disease

Ahmad A Ballout - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

A Novel Microfluidic Model Of Ischemic Stroke Recapitulating Arterial Occlusion And Prolonged Retraction

Rassam Rassam - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Activase I.V.

Randomized, Double-blind, Placebo-controlled Phase 1 Study Of Vwf-binding Aptamer, Bb-031: Safety, Tolerability, Pharmacokinetic And Pharmacodynamic Activity In Healthy Volunteers

Shahid M Nimjee - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Incidence And Predictors Of Dural Arteriovenous Fistulae After Cerebral Venous Sinus Thrombosis: Analysis Of ACTION-CVT

Aaron Shoskes - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Warfarin

Cerebral Venous Sinus Thrombosis Due To Vaccine-induced Immune Thrombotic Thrombocytopenia In Middle-Income Countries

Anita van de Munckhof - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Timing And Predictors Of Recanalization After Cerebral Venous Thrombosis

Setareh Salehi Omran - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Outcomes And Recurrence Rates Among Patients With Provoked And Cryptogenic Cerebral Venous Thrombosis: Analysis Of The ACTION CVT Study

Eyad Almallouhi - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Filters

7277 Abstracts